Behavioral treatments for speech in Parkinson's disease: meta-analyses and review of the literature.
Identifieur interne : 000436 ( PubMed/Curation ); précédent : 000435; suivant : 000437Behavioral treatments for speech in Parkinson's disease: meta-analyses and review of the literature.
Auteurs : Cyril Atkinson-Clement [France] ; Jasmin Sadat [France] ; Serge Pinto [France]Source :
- Neurodegenerative disease management [ 1758-2032 ] ; 2015.
English descriptors
- KwdEn :
- MESH :
- methods : Behavior Therapy, Speech Therapy.
- physiopathology : Parkinson Disease, Speech Disorders.
- therapy : Parkinson Disease, Speech Disorders.
- Humans, Speech.
Abstract
Parkinson's disease (PD) results from neurodegenerative processes leading to alteration of motor functions. Most motor symptoms respond well to pharmacological and neurosurgical treatments, except some axial symptoms such as speech impairment, so-called dysarthria. However, speech therapy is rarely proposed to PD patients. This review aims at evaluating previous research on the effects of speech behavioral therapies in patients with PD. We also performed two meta-analyses focusing on speech loudness and voice pitch. We showed that intensive therapies in PD are the most effective for hypophonia and can lead to some improvement of voice pitch. Although speech therapy is effective in handling PD dysarthria, behavioral speech rehabilitation in PD still needs further validation.
DOI: 10.2217/nmt.15.16
PubMed: 26107322
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000444
Links to Exploration step
pubmed:26107322Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Behavioral treatments for speech in Parkinson's disease: meta-analyses and review of the literature.</title>
<author><name sortKey="Atkinson Clement, Cyril" sort="Atkinson Clement, Cyril" uniqKey="Atkinson Clement C" first="Cyril" last="Atkinson-Clement">Cyril Atkinson-Clement</name>
<affiliation wicri:level="1"><nlm:affiliation>Aix-Marseille Université, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, 13100, Aix-en-Provence, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Aix-Marseille Université, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, 13100, Aix-en-Provence</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Sadat, Jasmin" sort="Sadat, Jasmin" uniqKey="Sadat J" first="Jasmin" last="Sadat">Jasmin Sadat</name>
<affiliation wicri:level="1"><nlm:affiliation>Aix-Marseille Université, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, 13100, Aix-en-Provence, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Aix-Marseille Université, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, 13100, Aix-en-Provence</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pinto, Serge" sort="Pinto, Serge" uniqKey="Pinto S" first="Serge" last="Pinto">Serge Pinto</name>
<affiliation wicri:level="1"><nlm:affiliation>Aix-Marseille Université, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, 13100, Aix-en-Provence, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Aix-Marseille Université, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, 13100, Aix-en-Provence</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26107322</idno>
<idno type="pmid">26107322</idno>
<idno type="doi">10.2217/nmt.15.16</idno>
<idno type="wicri:Area/PubMed/Corpus">000444</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000444</idno>
<idno type="wicri:Area/PubMed/Curation">000436</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000436</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Behavioral treatments for speech in Parkinson's disease: meta-analyses and review of the literature.</title>
<author><name sortKey="Atkinson Clement, Cyril" sort="Atkinson Clement, Cyril" uniqKey="Atkinson Clement C" first="Cyril" last="Atkinson-Clement">Cyril Atkinson-Clement</name>
<affiliation wicri:level="1"><nlm:affiliation>Aix-Marseille Université, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, 13100, Aix-en-Provence, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Aix-Marseille Université, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, 13100, Aix-en-Provence</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Sadat, Jasmin" sort="Sadat, Jasmin" uniqKey="Sadat J" first="Jasmin" last="Sadat">Jasmin Sadat</name>
<affiliation wicri:level="1"><nlm:affiliation>Aix-Marseille Université, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, 13100, Aix-en-Provence, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Aix-Marseille Université, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, 13100, Aix-en-Provence</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pinto, Serge" sort="Pinto, Serge" uniqKey="Pinto S" first="Serge" last="Pinto">Serge Pinto</name>
<affiliation wicri:level="1"><nlm:affiliation>Aix-Marseille Université, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, 13100, Aix-en-Provence, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Aix-Marseille Université, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, 13100, Aix-en-Provence</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Neurodegenerative disease management</title>
<idno type="eISSN">1758-2032</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Behavior Therapy (methods)</term>
<term>Humans</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson Disease (therapy)</term>
<term>Speech</term>
<term>Speech Disorders (physiopathology)</term>
<term>Speech Disorders (therapy)</term>
<term>Speech Therapy (methods)</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Behavior Therapy</term>
<term>Speech Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term>
<term>Speech Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Parkinson Disease</term>
<term>Speech Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Speech</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Parkinson's disease (PD) results from neurodegenerative processes leading to alteration of motor functions. Most motor symptoms respond well to pharmacological and neurosurgical treatments, except some axial symptoms such as speech impairment, so-called dysarthria. However, speech therapy is rarely proposed to PD patients. This review aims at evaluating previous research on the effects of speech behavioral therapies in patients with PD. We also performed two meta-analyses focusing on speech loudness and voice pitch. We showed that intensive therapies in PD are the most effective for hypophonia and can lead to some improvement of voice pitch. Although speech therapy is effective in handling PD dysarthria, behavioral speech rehabilitation in PD still needs further validation.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26107322</PMID>
<DateCreated><Year>2015</Year>
<Month>06</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>03</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>06</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1758-2032</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>5</Volume>
<Issue>3</Issue>
<PubDate><Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Neurodegenerative disease management</Title>
<ISOAbbreviation>Neurodegener Dis Manag</ISOAbbreviation>
</Journal>
<ArticleTitle>Behavioral treatments for speech in Parkinson's disease: meta-analyses and review of the literature.</ArticleTitle>
<Pagination><MedlinePgn>233-48</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2217/nmt.15.16</ELocationID>
<Abstract><AbstractText>Parkinson's disease (PD) results from neurodegenerative processes leading to alteration of motor functions. Most motor symptoms respond well to pharmacological and neurosurgical treatments, except some axial symptoms such as speech impairment, so-called dysarthria. However, speech therapy is rarely proposed to PD patients. This review aims at evaluating previous research on the effects of speech behavioral therapies in patients with PD. We also performed two meta-analyses focusing on speech loudness and voice pitch. We showed that intensive therapies in PD are the most effective for hypophonia and can lead to some improvement of voice pitch. Although speech therapy is effective in handling PD dysarthria, behavioral speech rehabilitation in PD still needs further validation.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Atkinson-Clement</LastName>
<ForeName>Cyril</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Aix-Marseille Université, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, 13100, Aix-en-Provence, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sadat</LastName>
<ForeName>Jasmin</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Aix-Marseille Université, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, 13100, Aix-en-Provence, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pinto</LastName>
<ForeName>Serge</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Aix-Marseille Université, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, 13100, Aix-en-Provence, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017418">Meta-Analysis</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Neurodegener Dis Manag</MedlineTA>
<NlmUniqueID>101517977</NlmUniqueID>
<ISSNLinking>1758-2024</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Neurodegener Dis Manag. 2015 Oct;5(5):463</RefSource>
<PMID Version="1">26606053</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001521" MajorTopicYN="N">Behavior Therapy</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013060" MajorTopicYN="N">Speech</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013064" MajorTopicYN="N">Speech Disorders</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013070" MajorTopicYN="N">Speech Therapy</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Parkinson's disease</Keyword>
<Keyword MajorTopicYN="N">dysarthria</Keyword>
<Keyword MajorTopicYN="N">loudness</Keyword>
<Keyword MajorTopicYN="N">pitch</Keyword>
<Keyword MajorTopicYN="N">prosody</Keyword>
<Keyword MajorTopicYN="N">speech therapy</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>6</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>6</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26107322</ArticleId>
<ArticleId IdType="doi">10.2217/nmt.15.16</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000436 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000436 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:26107322 |texte= Behavioral treatments for speech in Parkinson's disease: meta-analyses and review of the literature. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:26107322" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonFranceV1
![]() | This area was generated with Dilib version V0.6.29. | ![]() |